WHO Still Planning Biosimilar Naming Guidance, Gives Update On Prequalification Pilot
Executive Summary
Despite putting it on hold last year, the World Health Organization is keeping its idea of biosimilar naming guidance alive. And at a recent conference it updated delegates on the pilot project for prequalifying biosimilar versions of infliximab and trastuzumab.